OBJECTIVES: To determine whether the graded severity of smoke inhalation is reflected by the acute pulmonary inflammatory response to injury. DESIGN: In a prospective observational study, we assessed the bronchoalveolar lavage fluid for both leukocyte differential and concentration of 28 cytokines, chemokines, and growth factors. Results were then compared to the graded severity of inhalation injury as determined by Abbreviated Injury Score criteria (0, none; 1, mild; 2, moderate; 3, severe; 4, massive). SETTING: All patients were enrolled at a single tertiary burn center. PATIENTS: The bronchoalveolar lavage fluid was obtained from 60 patients within 14 hrs of burn injury who underwent bronchoscopy for suspected smoke inhalation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Those who presented with worse grades of inhalation injury had higher plasma levels of carboxyhemoglobin and enhanced airway neutrophilia. Patients with the most severe inhalation injuries also had a greater requirement for tracheostomy, longer time on the ventilator, and a prolonged stay in the intensive care unit. Of the 28 inflammatory mediators assessed in the bronchoalveolar lavage fluid, 21 were at their highest in those with the worst inhalation injury scores (grades 3 and 4), the greatest of which was interleukin-8 (92,940 pg/mL, grade 4). When compared in terms of low inhalation injury (grades 1-2) vs. high inhalation injury (grades 3-4), we found significant differences between groups for interleukin-4, interleukin-6, interleukin-9, interleukin-15, interferon-γ, granulocyte-macrophage colony-stimulating factor, and monocyte chemotactic protein-1 (p < .05 for all). CONCLUSIONS: These data reveal that the degree of inhalation injury has basic and profound effects on burn patient morbidity, evokes complex changes of multiple alveolar inflammatory proteins, and is a determinant of the pulmonary inflammatory response to smoke inhalation. Accordingly, future investigations should consider inhalation injury to be a graded phenomenon.
OBJECTIVES: To determine whether the graded severity of smoke inhalation is reflected by the acute pulmonary inflammatory response to injury. DESIGN: In a prospective observational study, we assessed the bronchoalveolar lavage fluid for both leukocyte differential and concentration of 28 cytokines, chemokines, and growth factors. Results were then compared to the graded severity of inhalation injury as determined by Abbreviated Injury Score criteria (0, none; 1, mild; 2, moderate; 3, severe; 4, massive). SETTING: All patients were enrolled at a single tertiary burn center. PATIENTS: The bronchoalveolar lavage fluid was obtained from 60 patients within 14 hrs of burn injury who underwent bronchoscopy for suspected smoke inhalation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Those who presented with worse grades of inhalation injury had higher plasma levels of carboxyhemoglobin and enhanced airway neutrophilia. Patients with the most severe inhalation injuries also had a greater requirement for tracheostomy, longer time on the ventilator, and a prolonged stay in the intensive care unit. Of the 28 inflammatory mediators assessed in the bronchoalveolar lavage fluid, 21 were at their highest in those with the worst inhalation injury scores (grades 3 and 4), the greatest of which was interleukin-8 (92,940 pg/mL, grade 4). When compared in terms of low inhalation injury (grades 1-2) vs. high inhalation injury (grades 3-4), we found significant differences between groups for interleukin-4, interleukin-6, interleukin-9, interleukin-15, interferon-γ, granulocyte-macrophage colony-stimulating factor, and monocyte chemotactic protein-1 (p < .05 for all). CONCLUSIONS: These data reveal that the degree of inhalation injury has basic and profound effects on burn patient morbidity, evokes complex changes of multiple alveolar inflammatory proteins, and is a determinant of the pulmonary inflammatory response to smoke inhalation. Accordingly, future investigations should consider inhalation injury to be a graded phenomenon.
Authors: J L Rodriguez; C G Miller; W L Garner; G O Till; P Guerrero; N P Moore; M Corridore; D P Normolle; D J Smith; D G Remick Journal: J Trauma Date: 1993-05
Authors: Matthias Lange; Robert A Cox; Perenlei Enkhbaatar; Elbert B Whorton; Yoshimitsu Nakano; Atsumori Hamahata; Collette Jonkam; Aimalohi Esechie; Sanna von Borzyskowski; Lillian D Traber; Daniel L Traber Journal: Exp Lung Res Date: 2011-02-11 Impact factor: 2.459
Authors: D J Dries; G J Jurkovich; R V Maier; T P Clemmer; S N Struve; J A Weigelt; G G Stanford; D L Herr; H R Champion; F R Lewis Journal: Arch Surg Date: 1994-10
Authors: John H Frankel; Devin M Boe; Joslyn M Albright; Eileen B O'Halloran; Stewart R Carter; Christopher S Davis; Luis Ramirez; Ellen L Burnham; Richard L Gamelli; Majid Afshar; Elizabeth J Kovacs Journal: Exp Gerontol Date: 2017-10-26 Impact factor: 4.032
Authors: Kathleen A Harrison; Eric Romer; Jonathan Weyerbacher; Jesus A Ocana; Ravi P Sahu; Robert C Murphy; Lisa E Kelly; Townsend A Smith; Christine M Rapp; Christina Borchers; David R Cool; Gengxin Li; Richard Simman; Jeffrey B Travers Journal: J Invest Dermatol Date: 2018-05-30 Impact factor: 8.551
Authors: Asitha Jayawardena; Anne S Lowery; Christopher Wootten; Gregory R Dion; J Blair Summitt; Stuart McGrane; Alexander Gelbard Journal: J Burn Care Res Date: 2019-02-20 Impact factor: 1.845
Authors: Christopher S Davis; Scott E Janus; Michael J Mosier; Stewart R Carter; Jeffrey T Gibbs; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs Journal: Ann Surg Date: 2013-06 Impact factor: 12.969
Authors: Benny L Joyner; Samuel W Jones; Bruce A Cairns; Bradford D Harris; Andrea M Coverstone; Kathleen A Abode; Shiara M Ortiz-Pujols; Keith C Kocis; Terry L Noah Journal: J Burn Care Res Date: 2013 May-Jun Impact factor: 1.845